10 likes | 261 Views
Table 4 Major ongoing phase III clinical trials of novel P2Y12-receptor inhibitors. Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.156.
E N D
Table 4 Major ongoing phase III clinical trials of novel P2Y12-receptor inhibitors Franchi, F. & Angiolillo, D. J. (2014) Novel antiplatelet agents in acute coronary syndrome Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.156